Key Takeaways
- • TCG Crossover ("TCG X"), a healthcare investment firm with teams in Palo Alto and New York City, has hired Simon Basseyn, M.D. to its New York City-based investment team, according to a Business Wire press release.
- • Basseyn most recently served as a senior analyst at Ghost Tree Capital, a New York-based life-sciences focused hedge fund.
- • Basseyn holds an M.D. from the Perelman School of Medicine at the University of Pennsylvania and an M.B.A. in Health Care Management from The Wharton School, and maintains an active New York medical license.
- • TCG X's Founding Managing Partner Chen Yu described Basseyn's technical background and cross-sector operating experience in health care as a fit for the firm.
Summary
TCG Crossover ("TCG X") has added Simon Basseyn, M.D. to its New York City-based investment team, the firm announced in a Business Wire release dated June 1, 2021. The firm, headquartered in Palo Alto, California, describes itself as a healthcare investment firm focused on advancing disruptive medicines and supporting companies that can improve patient outcomes. It invests in both private and public companies led by entrepreneurs developing better treatment options.
Prior to joining TCG X, Basseyn was a senior analyst at Ghost Tree Capital, a life-sciences focused hedge fund based in New York. His background includes internships in internal medicine at Weill Cornell/New York Presbyterian, management consulting at McKinsey & Company, and biotech venture capital at SR One. He holds an M.D. from the Perelman School of Medicine at the University of Pennsylvania and an M.B.A. in Health Care Management from The Wharton School, and currently maintains an active medical license in New York.
Basseyn said he was eager to begin investing in companies developing innovative science across the crossover and public stages. Chen Yu, Founding Managing Partner of TCG X, said Basseyn's technical background and diverse operating experience across the health care sector were a strong fit for the firm. The release did not disclose compensation, fund allocations, or specific investment mandates.
Prior to joining TCG X, Basseyn was a senior analyst at Ghost Tree Capital, a life-sciences focused hedge fund based in New York. His background includes internships in internal medicine at Weill Cornell/New York Presbyterian, management consulting at McKinsey & Company, and biotech venture capital at SR One. He holds an M.D. from the Perelman School of Medicine at the University of Pennsylvania and an M.B.A. in Health Care Management from The Wharton School, and currently maintains an active medical license in New York.
Basseyn said he was eager to begin investing in companies developing innovative science across the crossover and public stages. Chen Yu, Founding Managing Partner of TCG X, said Basseyn's technical background and diverse operating experience across the health care sector were a strong fit for the firm. The release did not disclose compensation, fund allocations, or specific investment mandates.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.